108 related articles for article (PubMed ID: 18497973)
1. Apoptosis in B-CLL: the relationship between higher ex vivo spontaneous apoptosis before treatment in III-IV Rai stage patients and poor outcome.
Sieklucka M; Pozarowski P; Bojarska-Junak A; Hus I; Dmoszynska A; Rolinski J
Oncol Rep; 2008 Jun; 19(6):1611-20. PubMed ID: 18497973
[TBL] [Abstract][Full Text] [Related]
2. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
5. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
Pangalis GA; Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kyrtsonis MC; Konstantopoulos K; Tsaftaridis P; Vaiopoulos GA; Kontopidou FN
Haematologica; 2002 May; 87(5):500-6. PubMed ID: 12010663
[TBL] [Abstract][Full Text] [Related]
6. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
9. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
10. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
Montserrat E; Bosch F; Rozman C
J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.
Campo S; Campo GM; Avenoso A; D'Ascola A; Musolino C; Calabrò L; Bellomo G; Quartarone E; Calatroni A
Biochimie; 2006 Dec; 88(12):1933-9. PubMed ID: 16938379
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
13. [Ribosome content, spontaneous damage and repairing DNA synthesis in patients with chronic B-lymphocytic leukemia depending on stage and form of disease].
Morozova EO; Samuskevich IG; Blinov MN
Eksp Onkol; 1990; 12(3):28-31. PubMed ID: 2344820
[TBL] [Abstract][Full Text] [Related]
14. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin gene rearrangements and in vitro growth of stromal cells are prognostic indexes in B-chronic lymphocytic leukemia.
Tripputi P; Bignotto M; Cigognini D; Pellegrini C; Corneo G
Ann Ital Med Int; 2004; 19(3):171-4. PubMed ID: 15529944
[TBL] [Abstract][Full Text] [Related]
16. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
[TBL] [Abstract][Full Text] [Related]
17. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.
van Gent R; Kater AP; Otto SA; Jaspers A; Borghans JA; Vrisekoop N; Ackermans MA; Ruiter AF; Wittebol S; Eldering E; van Oers MH; Tesselaar K; Kersten MJ; Miedema F
Cancer Res; 2008 Dec; 68(24):10137-44. PubMed ID: 19074880
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.
Chiorazzi N
Best Pract Res Clin Haematol; 2007 Sep; 20(3):399-413. PubMed ID: 17707829
[TBL] [Abstract][Full Text] [Related]
19. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
20. [Nitric oxide in supernatants of leukocytes and the serum of patients with B-CLL].
Jabłońska E; Kiersnowska-Rogowska B; Puzewska W; Rogowski F; Parfieńczyk A
Przegl Lek; 2006; 63(12):1286-90. PubMed ID: 17642141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
